Medprin Regenerative Medical Technologies (301033.SZ): Absorbable regenerative oxidized cellulose hemostatic particles have entered the clinical trial stage.
Map Medical (301033.SZ) announcement, the company's research and development project "absorbable regenerated cellulose hemostatic particles" ...
Medprin Regenerative Medical Technologies (301033.SZ) announces that the company's research and development project "Absorbable Regenerated Oxidized Cellulose Hemostatic Particles" has officially entered the clinical trial phase recently. In surgical procedures, when conventional methods of hemostasis such as ligation are not feasible or ineffective, this product can be used as an adjunct hemostatic product to control oozing from capillaries, veins, and small arteries.
Related Articles
ATV Holdings (00707) receives original complaint summons.
Apple Inc. CEO Cook stated that he will work together to promote chip packaging business, and the stock price of AMKR.US soared before the market.
ATV Holdings (00707) has received additional resumption guidelines from the Hong Kong Stock Exchange.
ATV Holdings (00707) receives original complaint summons.
Apple Inc. CEO Cook stated that he will work together to promote chip packaging business, and the stock price of AMKR.US soared before the market.
ATV Holdings (00707) has received additional resumption guidelines from the Hong Kong Stock Exchange.
